Literature DB >> 22934739

Preoperative hemostasis and its association with bleeding and blood component transfusion requirements in cardiopulmonary bypass surgery.

Nahit Emeklibas1, Inna Kammerer, Juergen Bach, Falk-Udo Sack, Peter Hellstern.   

Abstract

BACKGROUND: Variables of hemostasis before surgery might indicate an elevated risk of bleeding. We determined hemostasis tests and standardized bleeding history and their association with bleeding and transfusion requirements in cardiopulmonary bypass (CPB) surgery. STUDY DESIGN AND METHODS: In a prospective trial, variables from 104 patients were associated with postsurgical bleeding and with red blood cells (RBCs) and platelet concentrate (PC) transfusions. Variables included standardized bleeding history, prothrombin time (PT), fibrinogen, fibrin monomers, Factor VIII, von Willebrand factor (VWF), multiple electrode aggregation (MEA), and the day of aspirin or thienopyridine withdrawal before operation.
RESULTS: Multiple linear regression revealed bleeding history score, ADP-induced MEA, CPB time, and hemoglobin (Hb) independently associated with postoperative bleeding and bleeding history, arachidonic acid (AA)-induced MEA, CPB time, and PT associated with RBC transfusions. The logistic regression model for the outcome of bleeding within 24 hours after operation indicated ADP-induced MEA, the day of aspirin withdrawal before operation, and CPB time as predictors. AA-induced MEA, CPB time, Hb, and PT were predictors of RBCs transfusion. ADP-induced MEA, the day of aspirin withdrawal, PT, and VWF were associated with PC transfusion.
CONCLUSIONS: A standardized bleeding history may help to identify patients undergoing CPB surgery whose risk of bleeding is elevated. ADP-induced MEA appears to predict postoperative bleeding and PC transfusion requirements, while AA-induced MEA and preoperative Hb indicate the need for RBCs. The time of aspirin withdrawal before surgery influences perioperative blood loss and PC transfusion.
© 2012 American Association of Blood Banks.

Entities:  

Mesh:

Year:  2012        PMID: 22934739     DOI: 10.1111/j.1537-2995.2012.03885.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  5 in total

Review 1.  Coming safely to a stop: a review of platelet activity after cessation of antiplatelet drugs.

Authors:  Isobel Ford
Journal:  Ther Adv Drug Saf       Date:  2015-08

2.  Novel hemostatic patch achieves sutureless epicardial wound closure during complex cardiac surgery, a case report.

Authors:  Jayant S Jainandunsing; Sali Al-Ansari; Bozena D Woltersom; Thomas W L Scheeren; Ehsan Natour
Journal:  J Cardiothorac Surg       Date:  2015-01-27       Impact factor: 1.637

3.  Diagnostic evaluation of risk for bleeding in cardiac surgery with extracorporeal circulation.

Authors:  Damaris Vieira Braga; Marcos Antônio Gomes Brandão
Journal:  Rev Lat Am Enfermagem       Date:  2018-11-29

4.  Contribution of Coagulopathy on the Risk of Bleeding After Central Venous Catheter Placement in Critically Ill Thrombocytopenic Patients.

Authors:  Floor L F van Baarle; Arezoe Tisheh; Shanisa S Jhingoeriesingh; Alexander P J Vlaar; Bart J Biemond
Journal:  Crit Care Explor       Date:  2022-01-21

Review 5.  Biomarkers in Coronary Artery Bypass Surgery: Ready for Prime Time and Outcome Prediction?

Authors:  Alessandro Parolari; Paolo Poggio; Veronika Myasoedova; Paola Songia; Giorgia Bonalumi; Alberto Pilozzi; Davide Pacini; Francesco Alamanni; Elena Tremoli
Journal:  Front Cardiovasc Med       Date:  2016-01-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.